MELBOURNE, Australia - February 24, 2026 - Heidi, the leading healthcare AI platform, today announced a major milestone in its mission to redefine how healthcare is delivered: the launch of "Heidi Evidence". This comes alongside the launch of Heidi Comms, an AI partner for healthcare teams to coordinate patient communications across calls, bookings, reminders and follow-ups.
MIMS is pleased to announce that Heidi Health is the newest MIMS ANZ Integrated partner. Through this collaboration, MIMS clinical content will be available directly within Heidi Evidence across the ANZ region – a clinical grade research tool that gives clinicians independent, unlimited answers from trusted sources.
MIMS is the ANZ market leader in delivering trusted, high?quality and independent medicines information to ANZ healthcare professionals. With over 100 vendor partners across verticals of the healthcare section.
“This collaboration with Heidi Health marks an important step forward as we continue broadening the reach of MIMS’ trusted medicines information across diverse digital health assets. With our strong existing footprint in clinical software, expanding into an advanced AI?driven platform represents a significant milestone for MIMS and the clinicians we support.” said Robert Best, CEO of MIMS Australia and New Zealand
"We believe that for AI to be a true care partner, the integrity of its evidence must be non-negotiable," said Dr. Thomas Kelly, Co-Founder and CEO of Heidi.
He added: "As we see more general-purpose AI platforms like OpenAI move toward ad-supported models, consumers are rightly concerned about hidden influence. In a healthcare setting, that concern becomes paramount. Bringing transparent, clinical-grade insights into the room makes it easier to deliver quality care, but that information must be free from the ambiguity of commercial influence. By committing to Evidence being ad-free and independent, we ensure clinicians can stay present with their patients, knowing their decision-making is built on pure clinical rigor, not a business model."